IndraLab

Statements

RBM15 leads to the methylation of OTUB2. 1 / 1

| 1

reach

"Similarly, in cervical cancer, RBM15 inhibition reduces m6A methylation of OTUB2, leading to the inactivation of the AKT/mTOR pathway, which in turn decreases cell proliferation and metastasis capacity (Song and Wu 2023)."

39716068

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

RBM15 leads to the methylation of OTUB2. 1 / 1

INDRA sources:

Databases

Reading